Thyroid Carcinoma study: PET/CT Scan vs Iodine-124
Official title Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
ClinicalTrials.gov ID: NCT03647358
What this study is testing
What is Iodine-124?
an investigational PET imaging agent being studied to assess radioiodine uptake in thyroid carcinoma is designed to be taken up by thyroid cells and emit detectable signals for PET imaging
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study aims to find out if a PET scan using iodine‑124 can accurately measure iodine uptake in metastatic thyroid cancer and help doctors decide whether standard radioiodine therapy is likely to work.
- Who it's for
- Adults with metastatic thyroid carcinoma.
- What's involved
- Participants will undergo a PET imaging test that uses a special form of iodine (iodine‑124) to image the cancer. No new treatment is given as part of the study.
- Time commitment
- One imaging appointment, typically lasting a few hours, with any follow‑up visits as needed for results.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults with thyroid carcinoma confirmed by pathology.
- Adult thyroid carcinoma patients who have undergone total thyroidectomy
- Adult thyroid carcinoma patients have metastatic disease or suspicion for metastatic disease, or are under a protocol intended to explore...
- The patient and physician are planning to administer 131I for therapy if persistent radioiodine-avid metastases are present.
- All people must have measurable disease, documented within the previous six months by ultrasonography (US), MRI, FDG PET/CT, or CT scanning.
You likely can't join if
- Age less than 18 years.
- Patients who are pregnant.
The study team makes the final eligibility decision.
Where it is enrolling
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.